Naloxone B. Braun Melsungen (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone B. Braun Melsungen, is an opioid antagonist presented as an injectable solution for intramuscular or intravenous use. It is indicated for the rapid reversal of life‑threatening opioid overdose and for restoring normal breathing in patients with opioid‑induced respiratory depression, acting within minutes after administration.

GNH USA supplies Naloxone B. Braun Melsungen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing products that meet EU quality standards and ensuring reliable delivery across global markets.

Naloxone is an opioid antagonist used in the management of opioid overdose and related respiratory depression. - Opioid overdose: rapidly reverses life‑threatening respiratory depression and restores consciousness. - Opioid‑induced respiratory depression: restores normal breathing in patients receiving opioid analgesia. - Post‑operative opioid sedation: counteracts excessive opioid effects to re‑establish adequate ventilation.

Naloxone may be associated with several adverse reactions, most of which are related to its pharmacologic action or the route of administration.

Common Side Effects: - Injection site pain - Nausea - Vomiting - Sweating - Dizziness

Serious or Rare Side Effects: - Severe hypertension - Cardiac arrhythmia - Seizures - Pulmonary edema - Anaphylactic reaction

When using Naloxone, clinicians should observe specific precautions to ensure safe and effective reversal of opioid effects. - Confirm opioid exposure: verify suspected opioid overdose before administration. - Monitor respiratory status: observe patient continuously for re‑emergence of depression after naloxone wears off. - Assess for hypersensitivity: avoid use in individuals with known allergy to naloxone or formulation components. - Use cautiously in cardiovascular disease: rapid reversal may cause hypertension or tachycardia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone can interact with other substances that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid): - High‑dose opioids: may precipitate severe acute withdrawal. - Sympathomimetic agents: combined use can lead to marked hypertension. - Monoamine oxidase inhibitors: may enhance catecholamine effects and increase blood pressure.

Moderate Interactions (Monitor Closely): - Benzodiazepines: can mask withdrawal symptoms and alter sedation levels. - Alcohol: may increase risk of recurrent respiratory depression after naloxone effect diminishes.